| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035961 |
| Receipt No. | R000040958 |
| Official scientific title of the study | Randomized controlled trial on immunomodulatory Effects of Azithromycin in Children with Steroid Dependent Nephrotic Syndrome |
| Date of disclosure of the study information | 2019/02/26 |
| Last modified on | 2019/02/26 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Randomized controlled trial on immunomodulatory Effects of Azithromycin in Children with Steroid Dependent Nephrotic Syndrome
|
|
| Title of the study (Brief title) | Immunomodulatory effect of azithromycin on SDNS | |
| Region |
|
|
| Condition | |||
| Condition | complteted | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To compare the immunomodulatory effects of AZM combined with steroid therapy with that of steroid therapy alone in children with SDNS |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Comparison of TNF in both studied groups at different points throughout the study period. |
| Key secondary outcomes | - Reported significant persistent adverse effects of AZM
- Poor compliance of the patients - Occurrence of relapse |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Azithromycin 10mg/kg/d for 3 days and the course was repeated over 5 months
+ prednisone 1.5 mg/kg every other day for 1 month then 1 mg/kg every other day for 2 months then 0.5 mg/kg every other day for 2 months |
|
| Interventions/Control_2 | prednisone 1.5 mg/kg every other day for 1 month then 1 mg/kg every other day for 2 months then 0.5 mg/kg every other day for 2 months | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | - Patients with idiopathic steroid dependent nephrotic syndrome (SDNS) in relapse | |||
| Key exclusion criteria | - Patients have received immunosuppressive or cytotoxic drugs other than steroids.
- Patients with impaired liver functions, or with baseline risk of cardiovascular disease (i.e. prolonged QT syndrome, abnormally slow heart rate, congenital or acquired cardiac diseases or low levels of potassium and magnesium) - Secondary nephrotic syndrome |
|||
| Target sample size | 57 | |||
| Research contact person | |
| Name of lead principal investigator | Happy Sawires |
| Organization | Cairo University |
| Division name | Pediatric Nephrology |
| Address | 5 El-Lithy Street El-Maadi- Cairo - Egypt |
| TEL | +201005446448 |
| happy7_kd@yahoo.com | |
| Public contact | |
| Name of contact person | Heba Mostafa |
| Organization | Beni Suef University |
| Division name | Pediatric Nephrology |
| Address | Beni Suef |
| TEL | +201001516641 |
| Homepage URL | |
| heba_most@yahoo.com | |
| Sponsor | |
| Institute | Cairo University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Not applicable |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040958 |